// App-Quantinova.ai

1142 : Postpartum Venous Thromboembolic Events Among Carriers of Factor V Leiden and/or Prothrombin Gene Variant: A Cohort Study and Updated Systematic Review. Is Prophylaxis Really Required?

Researchers

Presenter

  • Gregoire Le Gal

Principal Investigators

  • Genevieve Le Templier

  • Nancy Carson

  • Shi Wu Wen

  • Marc A. Rodger

  • Mark Walker

  • Graeme N Smith

  • Phil Wells

  • Timothy Ramsay

  • Nicole Langlois

Medical Centers

  • Center for Continuing Education, University of Sherbrooke, Sherbrooke, QC, Canada

  • Division of Maternal Fetal Medicine, University of Ottawa, Ottawa, ON, Canada

  • Children's Hosptial of Eastern Ontario, Molecular Genetics Diagnostic Laboratory, Ottawa, ON, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Research Associate, Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Pediatrics, Queens University, Kingston, ON, Canada

  • University of Ottawa, Ottawa, ON, Canada

  • Department of Obstetrics & Gynecology, University of Ottawa, Ottawa, ON, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Superficial Vein Thrombosis

  • Venous thrombosis

  • Stroke

Biomarkers

  • Prothrombin

Drug/Treatment

  • Protein C

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved